Brief: Dariohealth Corp - Sees Increased Demand For Oral Glp-1 Solution
March 3 (Reuters) - DarioHealth Corp DRIO.O: DARIOHEALTH CORP - SEES INCREASED DEMAND FOR ORAL GLP-1 SOLUTION Source text: ID:nPn6N8XSla Further company coverage: DRIO.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on DarioHealth
See all newsNASDAQ RESUMED AT 10:02 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:57 AM
DarioHealth Corp reports results for the quarter ended June 30 - Earnings Summary
DarioHealth Q2 revenue falls on pharma exit; gross margin improves
DarioHealth Corp expected to post a loss of $1.21 a share - Earnings Preview